Patent · US Active

Modulating expression of polypeptides via new gene switch expression systems

US11692194B2 · kind B2 · utility

1Cited by
15References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 10, 2018
Grant dateJul 4, 2023
Priority date
Expiry dateJan 10, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/002
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are polynucleotides encoding ligand-inducible gene switch polypeptides, and systems comprising gene switch polypeptides for modulating the expression of a heterologous gene and an interleukin in a host cell. The compositions, methods and systems described herein facilitate ligand dependent expression of polypeptides including but not limited to cytokines and antigen binding polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.